United States · FDA National Drug Code directory
Loteprednol etabonate and tobramycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82260-358_48d4400d-e246-f109-e063-6394a90a8103
- Product NDC
- 82260-358
- Form
- SOLUTION/ DROPS
- Composition / generic term
- loteprednol etabonate and tobramycin
- Labeler
- Bausch & Lomb Americas Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20260109
- Source listing expiry
- 20271231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
- TOBRAMYCIN — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (82260-358-05) / 5 mL in 1 BOTTLE, DROPPER · 82260-358-05
- 1 BOTTLE, DROPPER in 1 CARTON (82260-358-10) / 10 mL in 1 BOTTLE, DROPPER · 82260-358-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →